CN112080156B - Water-soluble dye containing pyrene and preparation method thereof - Google Patents

Water-soluble dye containing pyrene and preparation method thereof Download PDF

Info

Publication number
CN112080156B
CN112080156B CN202011078909.0A CN202011078909A CN112080156B CN 112080156 B CN112080156 B CN 112080156B CN 202011078909 A CN202011078909 A CN 202011078909A CN 112080156 B CN112080156 B CN 112080156B
Authority
CN
China
Prior art keywords
compound
pyrene
hydrogen
soluble dye
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN202011078909.0A
Other languages
Chinese (zh)
Other versions
CN112080156A (en
Inventor
曲大辉
刘月
王骞
王梦奇
时召涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
East China University of Science and Technology
Original Assignee
East China University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by East China University of Science and Technology filed Critical East China University of Science and Technology
Priority to CN202011078909.0A priority Critical patent/CN112080156B/en
Publication of CN112080156A publication Critical patent/CN112080156A/en
Application granted granted Critical
Publication of CN112080156B publication Critical patent/CN112080156B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B26/00Hydrazone dyes; Triazene dyes
    • C09B26/02Hydrazone dyes
    • C09B26/04Hydrazone dyes cationic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a pyrene-containing water-soluble dye, which has a general formula shown as a formula I:
Figure DDA0002717242840000011
the pyrene-containing water-soluble dye component with broadened fluorescence emission spectrumThe method has the advantages of reasonable sub-design, novel synthetic target, better water solubility, easy control of synthetic conditions, simpler product purification, universality, simple synthetic steps and mild reaction conditions.

Description

Water-soluble dye containing pyrene and preparation method thereof
Technical Field
The invention belongs to the technical field of organic chemical synthesis, and particularly relates to a novel pyrene-containing water-soluble dye and a preparation method thereof.
Background
The pyrene unit is widely used as a fluorophore, the fluorescence lifetime is long, the quantum yield is high, when the pyrene unit is stacked in a dimer form, a red-shifted excimer can be generated to emit light, and the pyrene derivative has excellent optical properties and has important application in the aspects of fluorescent probes, fluorescent dyes, fluorescent chemical sensors and the like. However, the absorption spectrum is in the near ultraviolet region, deep blue light is emitted at low concentration, the covered light emitting region is limited, and most organic compounds synthesized based on pyrene are insoluble in water, which undoubtedly limits the use of pyrene-based derivatives. At present, the research on water-soluble pyrene-containing compounds is less, so that the method for simply and efficiently synthesizing the pyrene-containing water-soluble compounds through reasonable molecular design has important research significance and practical value.
Disclosure of Invention
The first purpose of the invention is to provide a pyrene-containing water-soluble dye with broadened fluorescence emission spectrum.
The second purpose of the invention is to provide a preparation method of the pyrene-containing water-soluble dye with broadened fluorescence emission spectrum.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
the first aspect of the invention provides a pyrene-containing water-soluble dye, which has a general formula shown in formula I:
Figure BDA0002717242820000011
wherein R is1Is composed of
Figure BDA0002717242820000012
n is a positive integer greater than or equal to 2; r2、R3、R4、R5、R6、R7、R8、R9、R10Are all hydrogen;
or, R1、R3At the same time are
Figure BDA0002717242820000021
n is a positive integer greater than or equal to 2; r2、R4、R5、R6、R7、R8、R9、R10Are all hydrogen;
or, R1、R6At the same time are
Figure BDA0002717242820000022
n is a positive integer greater than or equal to 2; r2、R3、R4、R5、R7、R8、R9、R10Are all hydrogen;
or, R1、R8At the same time are
Figure BDA0002717242820000023
n is a positive integer greater than or equal to 2; r2、R3、R4、R5、R6、R7、R9、R10Are all hydrogen;
or, R2、R7At the same time are
Figure BDA0002717242820000024
n is a positive integer greater than or equal to 2; r1、R3、R4、R5、R6、R8、R9、R10Are all hydrogen.
More preferably, the pyrene-containing water-soluble dye comprises:
wherein R is1Is one of the following structures:
Figure BDA0002717242820000025
R2、R3、R4、R5、R6、R7、R8、R9、R10are all hydrogen;
or, R1、R3And one of the following structures:
Figure BDA0002717242820000026
R2、R4、R5、R6、R7、R8、R9、R10are all hydrogen;
or, R1、R6And one of the following structures:
Figure BDA0002717242820000027
R2、R3、R4、R5、R7、R8、R9、R10are all hydrogen;
or, R1、R8And one of the following structures:
Figure BDA0002717242820000031
R2、R3、R4、R5、R6、R7、R9、R10are all hydrogen;
or, R2、R7And one of the following structures:
Figure BDA0002717242820000032
R1、R3、R4、R5、R6、R8、R9、R10are all hydrogen.
More preferably, the pyrene-containing water-soluble dye comprises:
wherein R is1Is composed of
Figure BDA0002717242820000033
R2、R3、R4、R5、R6、R7、R8、R9、R10Are all hydrogen;
or, R1、R3At the same time are
Figure BDA0002717242820000034
R2、R4、R5、R6、R7、R8、R9、R10Are all hydrogen;
or, R1、R6At the same time are
Figure BDA0002717242820000035
R2、R3、R4、R5、R7、R8、R9、R10Are all hydrogen;
or, R1、R8At the same time are
Figure BDA0002717242820000036
R2、R3、R4、R5、R6、R7、R9、R10Are all hydrogen;
or, R2、R7At the same time are
Figure BDA0002717242820000037
R1、R3、R4、R5、R6、R8、R9、R10Are all hydrogen.
Most preferably, the structure of the pyrene-containing water-soluble dye is one of the following structures:
Figure BDA0002717242820000041
the second aspect of the invention provides a preparation method of the pyrene-containing water-soluble dye, which comprises the following steps:
Figure BDA0002717242820000051
dissolving a compound 1 and potassium carbonate in an acetonitrile solution at room temperature, adding dibromoalkane, and stirring and refluxing for 1-24 hours at the temperature of 70-90 ℃ under an argon atmosphere to obtain a compound 2; the molar ratio of the compound 1 to the potassium carbonate is 1:3, the molar ratio of the compound 1 to the dibromoalkane is 1: 5;
secondly, adding the compound 2 and trimethylamine into ethanol, and stirring and refluxing for 1-24 hours at the temperature of 70-90 ℃ under the argon atmosphere to obtain a compound 3; wherein the molar ratio of the compound 2 to the trimethylamine is 1: 5;
dissolving the compound 3 and hydrazine hydrate in methanol, and stirring and refluxing for 1-24 hours at the temperature of 70-90 ℃ under the argon atmosphere to obtain a compound 4; the molar ratio of the compound 3 to the hydrazine hydrate is 1 (5-50);
fourthly, dissolving the compound 4, 1-pyrene formaldehyde or pyrene substitute and excessive trifluoroacetic acid in ethanol, and stirring and refluxing for 1-24 hours at the temperature of 70-90 ℃ under the argon atmosphere to obtain a compound shown in the formula I, namely a water-soluble dye containing pyrene;
the molar ratio of the compound 4 to the 1-pyrene formaldehyde is 1: 1; the molar ratio of the compound 4 to the pyrene substituent was 2: 1.
The dibromoalkane is dibromoethane or dibromopropane.
The pyrene substitute is 1, 3-pyrene dicarboxaldehyde, 1, 6-pyrene dicarboxaldehyde, 1, 8-pyrene dicarboxaldehyde, 2, 7-pyrene dicarboxaldehyde.
Due to the adoption of the technical scheme, the invention has the following advantages and beneficial effects:
in order to widen the spectral region, the acylhydrazone groups are introduced into the pyrene units, the pi-conjugated skeleton is prolonged, the fluorescence emission wavelength is red-shifted, and the effect of hydrogen bonds among the acylhydrazone groups can be used as secondary non-covalent interaction to stabilize the primary stacking interaction of the pyrene units. The other end of the acylhydrazone group is covalently modified with a hydrophilic quaternary ammonium salt chain, so that the whole molecule becomes a typical amphiphilic structure and has water solubility. This feature drives the amphiphilic assembly of target molecules in aqueous solution, hydrophobic pyrene units are stacked internally, thus generating excimer emission. The reasonable molecular design ensures that the target compound has water solubility, widens the fluorescence spectrum of the target compound and realizes the synthesis of the pyrene-containing water-soluble dye.
The pyrene-containing water-soluble dye with broadened fluorescence emission spectrum has the advantages of reasonable molecular design, novel synthetic target, better water solubility, easy control of synthetic conditions, simpler product purification, universality, simple synthetic steps and mild reaction conditions.
Drawings
FIG. 1 is a drawing of Compound 8 prepared in example 1 of the present invention1H-NMR chart.
FIG. 2 is a schematic fluorescence spectrum of Compound 8 prepared in example 1 of the present invention.
FIG. 3 is a drawing of Compound 9 prepared in example 2 of the present invention1H-NMR chart.
FIG. 4 is a graph showing the fluorescence spectrum of Compound 9 prepared in example 2 of the present invention.
FIG. 5 is a photograph of Compound 10, prepared according to example 3 of the present invention1H-NMR chart.
FIG. 6 is a schematic fluorescence spectrum of Compound 10 prepared in example 3 of the present invention.
FIG. 7 is a photograph of Compound 11 prepared in example 4 of the present invention1H-NMR chart.
FIG. 8 is a graph showing the fluorescence spectrum of Compound 11 prepared in example 4 of the present invention.
FIG. 9 is a photograph of Compound 12 prepared in example 5 of the present invention1H-NMR chart.
FIG. 10 is a graph showing the fluorescence spectrum of Compound 12 prepared in example 5 of the present invention.
FIG. 11 is a photograph of a clear orange-yellow aqueous solution of Compound 11 prepared in example 4 of the present invention.
FIG. 12 is a graph showing a fluorescence spectrum of trisodium 8-hydroxypyrene-1, 3, 6-trisulfonate, a comparative example compound according to the present invention.
Detailed Description
In order to more clearly illustrate the invention, the invention is further described below in connection with preferred embodiments. It is to be understood by persons skilled in the art that the following detailed description is illustrative and not restrictive, and is not to be taken as limiting the scope of the invention.
The synthetic route of the intermediate compound required by the embodiment of the invention is as follows:
Figure BDA0002717242820000061
the preparation method of the compound 7 comprises the following steps:
(1) compound 1, methylparaben (5.0g, 33mmol) and potassium carbonate (13.8g, 100mmol) were dissolved in 350mL of acetonitrile solution at room temperature, dibromoethane (30.9g, 165mmol) was added to the solution, and the mixture was stirred and refluxed at 80 ℃ under argon atmosphere for 12 hours to obtain Compound 5 by substitution reaction. Wherein the molar ratio of compound 1 to potassium carbonate is 1: and 3, the molar ratio of the compound 1 to dibromoethane is 1: 5.
(2) adding the compound 5(5.1g, 19.6mmol) and trimethylamine (5.8g, 98mmol) into 200mL ethanol, and stirring and refluxing for 12h at 80 ℃ under an argon atmosphere to obtain the quaternary ammonium salt compound 6, wherein the molar ratio of the compound 5 to the trimethylamine is 1: 5.
(3) mixing the compound 6(4.1g, 12mmol), hydrazine hydrate (3.2g, 60mmol) and 120mL of methanol, and stirring and refluxing the mixture for 12h at the temperature of 70 ℃ under an argon atmosphere to obtain a compound 7, wherein the molar ratio of the compound 6 to the hydrazine hydrate is 1: 5.
example 1
Compound 7(0.1g, 0.31mmol), 1-pyrenecarboxaldehyde (0.07g, 0.31mmol), trifluoroacetic acid (10uL) were mixed with ethanol (40mL), stirred under reflux at 80 ℃ under argon atmosphere for 24 hours, and the reaction was monitored by TLC follow-up until the starting material was consumed. The reaction solution was cooled to room temperature, the solvent was distilled off under reduced pressure, and recrystallization was carried out to obtain 0.1g of compound 8 in a yield of 72%.
The specific synthetic route is as follows:
Figure BDA0002717242820000071
FIG. 1 is a drawing of Compound 8 prepared in example 1 of the present invention1An H-NMR chart of the sample,1H NMR(400MHz,DMSO-d6)δ=11.98(s,1H),9.55(s,1H),8.84(d,J=9.1Hz,1H),8.59(d,J=8.8Hz,1H),8.39(d,J=7.8Hz,3H),8.27(dd,J=18.3,8.9Hz,3H),8.15(m,1H),8.07(d,J=8.7Hz,2H),7.20(d,J=8.8Hz,2H),4.60(s,2H),3.84(s,2H),3.21(s,9H).
FIG. 2 is a diagram showing the fluorescence spectrum of Compound 8 prepared in example 1 of the present invention, which has a maximum fluorescence emission wavelength of 460 nm.
Example 2
Compound 7(0.2g, 0.62mmol), 1, 3-pyrenedicarbaldehyde (0.08g, 0.31mmol), trifluoroacetic acid (10uL) were mixed with ethanol (40mL), stirred under reflux at 80 ℃ under argon atmosphere for 24 hours, and the reaction was monitored by TLC follow-up to raw material exhaustion. The reaction solution was cooled to room temperature, the solvent was distilled off under reduced pressure, and recrystallization was carried out to obtain 0.15g of compound 9 in 56% yield.
The specific synthetic route is as follows:
Figure BDA0002717242820000081
FIG. 3 is a drawing of Compound 9 prepared in example 2 of the present invention1An H-NMR chart of the sample,1H NMR(400MHz,DMSO-d6)δ=12.03(s,2H),9.58(s,2H),8.91(d,J=7.8Hz,2H),8.64(d,J=7.7Hz,2H),8.44(m,4H),8.07(d,J=8.5Hz,4H),7.20(d,J=8.7Hz,4H),4.60(s,4H),3.85(s,4H),3.21(s,18H)。
FIG. 4 is a diagram showing a fluorescence spectrum of Compound 9 prepared in example 2 of the present invention, which has a fluorescence maximum emission wavelength of 625 nm.
Example 3
Compound 7(0.2g, 0.62mmol), 1, 6-pyrenedicarbaldehyde (0.08g, 0.31mmol), and trifluoroacetic acid (10uL) were mixed with ethanol (40mL), and stirred under reflux at 80 ℃ under an argon atmosphere for 24 hours. The mixture was cooled to room temperature, the solvent was distilled off under reduced pressure, and recrystallization was carried out to obtain 0.18g of compound 10 in 68% yield.
The specific synthetic route is as follows:
Figure BDA0002717242820000082
FIG. 5 is a photograph of Compound 10, prepared according to example 3 of the present invention1An H-NMR chart of the sample,1H NMR(400MHz,DMSO-d6)δ=12.10(s,2H),9.63(s,2H),8.89(d,J=9.0Hz,2H),8.63(d,J=7.8Hz,4H),8.33(m,4H),8.06(d,J=8.7Hz,4H),7.19(d,J=8.7Hz,4H),4.59(s,4H),3.85(s,4H),3.22(s,18H)。
FIG. 6 is a diagram showing a fluorescence spectrum of Compound 10 prepared in example 3 of the present invention, which has a fluorescence maximum emission wavelength of 625 nm.
Example 4
Compound 7(0.2g, 0.62mmol), 1, 8-pyrenedicarbaldehyde (0.08g, 0.31mmol), and trifluoroacetic acid (10uL) were mixed with ethanol (40mL), and stirred under reflux at 80 ℃ under an argon atmosphere for 24 hours. The mixture was cooled to room temperature, the solvent was distilled off under reduced pressure, and recrystallization was carried out to obtain 0.14g of compound 11 in 53% yield.
The specific synthetic route is as follows:
Figure BDA0002717242820000091
FIG. 7 is a photograph of Compound 11 prepared in example 4 of the present invention1An H-NMR chart of the sample,1H NMR(400MHz,DMSO-d6)δ=12.04(s,2H),9.58(s,2H),8.90(d,J=7.8Hz,2H),8.64(d,J=7.7Hz,2H),8.44(m,4H),8.07(d,J=8.6Hz,4H),7.21(d,J=8.7Hz,4H),4.60(s,4H),3.85(s,4H),3.22(s,18H)。
FIG. 8 is a diagram showing a fluorescence spectrum of Compound 11 prepared in example 4 of the present invention, which has a fluorescence maximum emission wavelength of 625 nm.
Example 5
Compound 7(0.2g, 0.62mmol), 2, 7-pyrenedicarbaldehyde (0.08g, 0.31mmol), and trifluoroacetic acid (10uL) were mixed with ethanol (40mL), and stirred under reflux at 80 ℃ under an argon atmosphere for 24 hours. The mixture was cooled to room temperature, the solvent was distilled off under reduced pressure, and recrystallization was carried out to obtain 0.16g of compound 12 in 60% yield.
The specific synthetic route is as follows:
Figure BDA0002717242820000092
FIG. 9 is a photograph of Compound 12 prepared in example 5 of the present invention1An H-NMR chart of the sample,1H NMR(400MHz,DMSO-d6)δ=12.05(s,2H),8.91(s,2H),8.66(s,2H),8.33(s,4H),8.06(d,J=8.3Hz,4H),7.19(d,J=8.7Hz,4H),4.59(s,4H),3.85(s,4H),3.22(s,18H)。
FIG. 10 is a diagram showing the fluorescence spectrum of Compound 12 prepared in example 5 of the present invention, which has a maximum fluorescence emission wavelength of 460 nm.
Example 6
36mg of Compound 11 was dissolved in 30mL of water to give an orange-yellow clear aqueous solution having a concentration of 8.33X 10- 4And mol/L shows that the pyrene-containing dye synthesized by the invention has good water solubility. Figure 11 is a yellow-orange clear aqueous solution of compound 11 prepared in example 4 of the present invention.
Comparative example 1
Due to the hydrophobicity of the pyrenyl group, most of the pyrene-containing dyes are insoluble in water at present, 8-hydroxypyrene-1, 3, 6-trisulfonic acid trisodium salt is one of the few existing pyrene dyes capable of being dissolved in water, the chemical structural formula of the pyrene-containing trisodium salt is shown as a formula II, and the pyrene-containing dye has strong green light emission near 512 nm.
Figure BDA0002717242820000101
FIG. 12 is a diagram showing a fluorescence spectrum of trisodium 8-hydroxypyrene-1, 3, 6-trisulfonate in a comparative example of the present invention, the fluorescence maximum emission wavelength of which is 512 nm.
Although the present invention has been described with reference to a preferred embodiment, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (6)

1. A pyrene-containing water-soluble dye is characterized in that the water-soluble dye is a compound shown in a formula I:
Figure FDA0003214528120000011
wherein R is1Is one of the following groups:
Figure FDA0003214528120000012
R2、R3、R4、R5、R6、R7、R8、R9、R10are all hydrogen;
or, R1、R3And is one of the following groups:
Figure FDA0003214528120000013
R2、R4、R5、R6、R7、R8、R9、R10are all hydrogen;
or, R1、R6And is one of the following groups:
Figure FDA0003214528120000014
R2、R3、R4、R5、R7、R8、R9、R10are all hydrogen;
or, R1、R8And is one of the following groups:
Figure FDA0003214528120000015
R2、R3、R4、R5、R6、R7、R9、R10are all hydrogen;
or, R2、R7And is one of the following groups:
Figure FDA0003214528120000016
R1、R3、R4、R5、R6、R8、R9、R10are all hydrogen.
2. The water-soluble dye according to claim 1, wherein,
R1is composed of
Figure FDA0003214528120000021
R2、R3、R4、R5、R6、R7、R8、R9、R10Are all hydrogen;
or, R1、R3At the same time are
Figure FDA0003214528120000022
R2、R4、R5、R6、R7、R8、R9、R10Are all hydrogen;
or, R1、R6At the same time are
Figure FDA0003214528120000023
R2、R3、R4、R5、R7、R8、R9、R10Are all hydrogen;
or, R1、R8At the same time are
Figure FDA0003214528120000024
R2、R3、R4、R5、R6、R7、R9、R10Are all hydrogen;
or, R2、R7At the same time are
Figure FDA0003214528120000025
R1、R3、R4、R5、R6、R8、R9、R10Are all hydrogen.
3. The water-soluble dye according to claim 2, wherein the water-soluble dye is one of the following compounds:
Figure FDA0003214528120000026
Figure FDA0003214528120000031
4. a process for preparing the water-soluble dye of claim 1, comprising the steps of:
Figure FDA0003214528120000032
dissolving a compound 1 and potassium carbonate in an acetonitrile solution at room temperature, adding dibromoalkane, and stirring and refluxing for 1-24 h under the argon atmosphere at the temperature of 70-90 ℃ to obtain a compound 2; the molar ratio of the compound 1 to the potassium carbonate is 1:3, and the molar ratio of the compound 1 to the dibromoalkane is 1: 5;
secondly, adding the compound 2 and trimethylamine into ethanol, and stirring and refluxing for 1-24 h under the argon atmosphere at the temperature of 70-90 ℃ to obtain a compound 3; wherein the molar ratio of the compound 2 to the trimethylamine is 1: 5;
thirdly, dissolving the compound 3 and hydrazine hydrate in methanol, and stirring and refluxing for 1-24 h under the argon atmosphere at the temperature of 70-90 ℃ to obtain a compound 4; the molar ratio of the compound 3 to the hydrazine hydrate is 1 (5-50);
fourthly, dissolving the compound 4, the 1-pyrene formaldehyde or pyrene substitute and excessive trifluoroacetic acid in ethanol, and stirring and refluxing for 1-24 h under the argon atmosphere at the temperature of 70-90 ℃ to obtain a compound shown in the formula I;
the molar ratio of the compound 4 to the 1-pyrene formaldehyde is 1: 1; the molar ratio of the compound 4 to the pyrene substituent is 2:1, and n is 2 or 3.
5. The method of claim 4, wherein the dibromoalkane is dibromoethane or dibromopropane.
6. The method of claim 4, wherein the pyrene substituent is 1, 3-pyrene dicarboxaldehyde, 1, 6-pyrene dicarboxaldehyde, 1, 8-pyrene dicarboxaldehyde or 2, 7-pyrene dicarboxaldehyde.
CN202011078909.0A 2020-10-10 2020-10-10 Water-soluble dye containing pyrene and preparation method thereof Expired - Fee Related CN112080156B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011078909.0A CN112080156B (en) 2020-10-10 2020-10-10 Water-soluble dye containing pyrene and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011078909.0A CN112080156B (en) 2020-10-10 2020-10-10 Water-soluble dye containing pyrene and preparation method thereof

Publications (2)

Publication Number Publication Date
CN112080156A CN112080156A (en) 2020-12-15
CN112080156B true CN112080156B (en) 2021-10-15

Family

ID=73730914

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011078909.0A Expired - Fee Related CN112080156B (en) 2020-10-10 2020-10-10 Water-soluble dye containing pyrene and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112080156B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114890980B (en) * 2022-05-16 2024-02-13 内蒙古大学 Process for preparing ionic thiafluorene derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012513459A (en) * 2008-12-23 2012-06-14 ルミナノ カンパニー リミテッド NOVEL ORGANIC SEMICONDUCTOR COMPOUND, PROCESS FOR PRODUCING THE SAME, ORGANIC SEMICONDUCTOR COMPOSITION CONTAINING THE SAME, ORGANIC SEMICONDUCTOR THIN FILM AND DEVICE
CN107090190B (en) * 2017-04-24 2019-09-06 北京科技大学 A kind of acridine salt dyestuff and its preparation method and application

Also Published As

Publication number Publication date
CN112080156A (en) 2020-12-15

Similar Documents

Publication Publication Date Title
CN108440475B (en) Ratio type fluorescent probe for distinguishing lipid droplets with different polarities and preparation method and application thereof
Xiao et al. Two novel aggregation-induced emission active coumarin-based Schiff bases and their applications in cell imaging
CN111995580B (en) Fluorescent dye with tetraphenyl ethylene imidazole ring structure and application thereof
CN106565606B (en) Compound and its preparation method and application with aggregation-induced emission property
CN106008192B (en) A kind of tetraphenyl ethylene base derovatives and application
CN106674028B (en) Benzylidene indene dione compound, preparation thereof and application thereof in lipid drop specific imaging
CN112080156B (en) Water-soluble dye containing pyrene and preparation method thereof
CN111825618B (en) Phenanthroimidazole-containing blue organic semiconductor material and preparation method and application thereof
CN113278000A (en) Coumarin-based red light aggregation-induced luminescent material and preparation method thereof
Papkovsky et al. Longwave luminescent porphyrin probes
CN110885340A (en) Europium-containing binuclear dual-ligand rare earth composite fluorescent material and preparation method thereof
CN107759504B (en) Dual-phase organic fluorescent material with strong fluorescence in solid and liquid states and preparation method thereof
CN113387905A (en) Organic room temperature phosphorescent material, preparation method and application
CN111574536B (en) Organic electroluminescent compound and preparation method and application thereof
Kawakami et al. Spectral characteristics of highly fluorescent 2-(N, N-dimethylamino) tryptanthrin
CN112047922A (en) Benzophenone and benzothiophene-based luminescent material and preparation method and application thereof
CN110028456B (en) Barbituric acid derivative and preparation method and application thereof
CN109988141B (en) Application of fluorescein derivative compound with up-conversion luminescence property based on thermal activation delayed fluorescence
CN108569992B (en) Polyketene compound, application of compound as dual-fluorescence emission organic luminescent material and preparation method of compound
CN114853656B (en) Carbazole derivative with AEE characteristic, preparation method and application
CN106366041B (en) It is a kind of it is continuous identification palladium ion, CO fluorescence probe and application
CN115819281A (en) Cyano-substituted p-phenylene ethylene derivative, preparation method and application
CN113912517B (en) Mechanochromic and mechanoluminescent photochromic compound and preparation method and application thereof
CN114671851B (en) Naphthalimide-tetrazine compound and preparation method and application thereof
CN112174988B (en) Tertiary rare earth terbium trimer and its preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20211015